Diane E Bennett

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs
    Diane E Bennett
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Emerg Infect Dis 8:1224-9. 2002
  2. pmc Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS Med 5:e158. 2008
  3. ncbi request reprint The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world
    Diane E Bennett
    Global AIDS Program, National Centre for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Curr Opin Infect Dis 19:607-14. 2006
  4. ncbi request reprint Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000
    Diane E Bennett
    Centers for Disease Control and Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia, USA
    Am J Respir Crit Care Med 177:348-55. 2008
  5. ncbi request reprint The World Health Organization's global strategy for prevention and assessment of HIV drug resistance
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    Antivir Ther 13:1-13. 2008
  6. ncbi request reprint HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam
    HIEN TRAN NGUYEN
    National Institute for Hygiene and Epidemiology, Hanoi, Vietnam
    Antivir Ther 13:115-21. 2008
  7. ncbi request reprint Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004
    Visva Pillay
    National Institute for Communicable Diseases, Johannesburg, South Africa
    Antivir Ther 13:101-7. 2008
  8. ncbi request reprint Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006
    Gugu Maphalala
    Swaziland Ministry of Health and Social Welfare, National Reference Laboratory, Mbabane, Swaziland
    Antivir Ther 13:95-100. 2008
  9. ncbi request reprint Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania
    Geofrey R Somi
    National AIDS Control Program, Dar es Salaam, Tanzania
    Antivir Ther 13:77-82. 2008
  10. ncbi request reprint Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies
    Robert W Shafer
    Division of Infectious Diseases, Stanford University, Stanford, CA, USA
    Antivir Ther 13:59-68. 2008

Collaborators

Detail Information

Publications15

  1. ncbi request reprint DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs
    Diane E Bennett
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Emerg Infect Dis 8:1224-9. 2002
    ..Foreign-born persons with TB may have been infected previously in high-prevalence countries; screening and preventive measures recommended by the Institute of Medicine could prevent TB reactivation in these cases...
  2. pmc Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS Med 5:e158. 2008
    ..We used sensitive and simple tests to investigate evidence of transmitted drug resistance in antiretroviral drug-naïve persons and assess the clinical implications of minority drug-resistant variants...
  3. ncbi request reprint The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world
    Diane E Bennett
    Global AIDS Program, National Centre for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Curr Opin Infect Dis 19:607-14. 2006
    ..To describe surveillance measures to inform HIV drug-resistance prevention, as part of the public health approach to antiretroviral therapy in developing countries...
  4. ncbi request reprint Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000
    Diane E Bennett
    Centers for Disease Control and Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia, USA
    Am J Respir Crit Care Med 177:348-55. 2008
    ..The goal for tuberculosis (TB) elimination in the United States is a TB disease incidence of less than 1 per million U.S. population by 2010, which requires that the latent TB infection (LTBI) prevalence be less than 1% and decreasing...
  5. ncbi request reprint The World Health Organization's global strategy for prevention and assessment of HIV drug resistance
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    Antivir Ther 13:1-13. 2008
    ..As of December 2007, 25 countries were planning or implementing the strategy; seven countries report results in this supplement...
  6. ncbi request reprint HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam
    HIEN TRAN NGUYEN
    National Institute for Hygiene and Epidemiology, Hanoi, Vietnam
    Antivir Ther 13:115-21. 2008
    ..Estimating transmitted resistance in the infected population will enable the appropriateness of current antiretroviral drug regimens to be assessed and will inform plans for future HIVDR surveillance...
  7. ncbi request reprint Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004
    Visva Pillay
    National Institute for Communicable Diseases, Johannesburg, South Africa
    Antivir Ther 13:101-7. 2008
    ....
  8. ncbi request reprint Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006
    Gugu Maphalala
    Swaziland Ministry of Health and Social Welfare, National Reference Laboratory, Mbabane, Swaziland
    Antivir Ther 13:95-100. 2008
    ..We used the WHO's HIVDR threshold survey method to assess transmitted HIVDR in three antenatal clinic (ANC) sites along the corridor between the two most populous cities in Swaziland, where ART was introduced in 2003...
  9. ncbi request reprint Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania
    Geofrey R Somi
    National AIDS Control Program, Dar es Salaam, Tanzania
    Antivir Ther 13:77-82. 2008
    ..We used the WHO HIVDR threshold survey method to assess transmitted HIVDR in Dar es Salaam where ART was introduced in 1995 and where approximately 11,000 people are currently on ART...
  10. ncbi request reprint Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies
    Robert W Shafer
    Division of Infectious Diseases, Stanford University, Stanford, CA, USA
    Antivir Ther 13:59-68. 2008
    ..The process used to create a previously published list of drug resistance mutations for HIV-1 surveillance is reviewed and alternative approaches to this process are discussed...
  11. ncbi request reprint A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings
    Mark Myatt
    Division of Epidemiology, Institute of Ophthalmology, University College London, London EC1V 9EL, UK
    Antivir Ther 13:37-48. 2008
    ..The method is currently being used in several such settings...
  12. ncbi request reprint Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    Antivir Ther 13:25-36. 2008
    ..Transmitted drug resistant HIV strains will be seen first in cities or health districts where antiretroviral treatment (ART) has been widely available for years. WHO recommends countries begin surveillance in these areas...
  13. ncbi request reprint World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites
    Michael R Jordan
    Tufts University School of Medicine, Boston, MA, USA
    Antivir Ther 13:15-23. 2008
    ..Performed regularly at representative sites, the data generated will inform evidence-based decision making regarding national and global ART regimen selection and minimize the emergence of HIVDR at a population level...
  14. pmc Identifying the sources of tuberculosis in young children: a multistate investigation
    Sumi J Sun
    California Department of Health Services, Berkley, CA, USA
    Emerg Infect Dis 8:1216-23. 2002
    ..Potential differences between sources for patients <5 years of age and source patients that transmitted TB to adolescent and adult patients were identified...
  15. doi request reprint Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model
    Andrew N Phillips
    HIV Epidemiology and Biostatistics Group, Department of Primary Care and Population Sciences, and Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, University College London, London, UK
    Lancet 371:1443-51. 2008
    ..Our aim was to study the potential consequences of such monitoring strategies, especially in terms of survival and resistance development...